Oster, H. and Mittelman, M. (2026) “Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall”, Haematologica. Pavia, Italy, 111(5), pp. 1523-1525. doi: 10.3324/haematol.2025.300405.